Inhibitor Therapeutics, Inc. (INTI) Operating cash flow 2016–2025
Inhibitor Therapeutics, Inc. (INTI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.2MFY2025 · since FY2016: -$3.8M → -$3.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.2M | +0.1% |
| FY2024 | -$3.2M | -19.7% |
| FY2023 | -$2.7M | -123.0% |
| FY2022 | $11.7M | +5426.2% |
| FY2021 | -$220,433 | +73.3% |
| FY2020 | -$825,357 | +69.5% |
| FY2019 | -$2.7M | +27.0% |
| FY2018 | -$3.7M | -27.3% |
| FY2017 | -$2.9M | +22.5% |
| FY2016 | -$3.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice